153 related articles for article (PubMed ID: 29071217)
1. Modafinil Improves Catalepsy in a Rat 6-Hydroxydopamine Model of Parkinson's Disease; Possible Involvement of Dopaminergic Neurotransmission.
Vajdi-Hokmabad R; Ziaee M; Sadigh-Eteghad S; Sandoghchian Shotorbani S; Mahmoudi J
Adv Pharm Bull; 2017 Sep; 7(3):359-365. PubMed ID: 29071217
[No Abstract] [Full Text] [Related]
2. Antidepressant-like effect of modafinil in mice: Evidence for the involvement of the dopaminergic neurotransmission.
Mahmoudi J; Farhoudi M; Talebi M; Sabermarouf B; Sadigh-Eteghad S
Pharmacol Rep; 2015 Jun; 67(3):478-84. PubMed ID: 25933957
[TBL] [Abstract][Full Text] [Related]
3. Buspirone improves the anti-cataleptic effect of levodopa in 6-hydroxydopamine-lesioned rats.
Mahmoudi J; Nayebi AM; Samini M; Reyhani-Rad S; Babapour V
Pharmacol Rep; 2011; 63(4):908-14. PubMed ID: 22001978
[TBL] [Abstract][Full Text] [Related]
4. Dose-Dependent Effect of Flouxetine on 6-OHDA-Induced Catalepsy in Male Rats: A Possible Involvement of 5-HT1A Receptors.
Sharifi H; Mohajjel Nayebia A; Farajnia S
Adv Pharm Bull; 2013; 3(1):203-6. PubMed ID: 24312836
[TBL] [Abstract][Full Text] [Related]
5. Role of 5-Hydroxytryptamine 1A Receptors in 6-Hydroxydopmaine-induced Catalepsy-like Immobilization in Rats: a Therapeutic Approach for Treating Catalepsy of Parkinson's Disease.
Eyhani-Rad S; Mohajjel Nayebi A; Mahmoudi J; Samini M; Babapour V
Iran J Pharm Res; 2012; 11(4):1175-81. PubMed ID: 24250551
[TBL] [Abstract][Full Text] [Related]
6. Modification of cataleptic responses to dopamine receptor antagonists after withdrawal from chronic cocaine or cocaine plus dopamine antagonist administration.
Ushijima I; Mizuki Y; Suetsugi M; Akimoto T; Yamada M
Prog Neuropsychopharmacol Biol Psychiatry; 1998 May; 22(4):709-21. PubMed ID: 9682282
[TBL] [Abstract][Full Text] [Related]
7. The effect of the alpha2-adrenoreceptor antagonist idazoxan against 6-hydroxydopamine-induced Parkinsonism in rats: multiple facets of action?
Srinivasan J; Schmidt WJ
Naunyn Schmiedebergs Arch Pharmacol; 2004 Jun; 369(6):629-38. PubMed ID: 15118809
[TBL] [Abstract][Full Text] [Related]
8. Pre-treatment with silymarin reduces brain myeloperoxidase activity and inflammatory cytokines in 6-OHDA hemi-parkinsonian rats.
Haddadi R; Mohajjel Nayebi A; Brooshghalan SE
Neurosci Lett; 2013 Oct; 555():106-11. PubMed ID: 24045063
[TBL] [Abstract][Full Text] [Related]
9. Dopamine D1- and D2-dependent catalepsy in the rat requires functional NMDA receptors in the corpus striatum, nucleus accumbens and substantia nigra pars reticulata.
Ozer H; Ekinci AC; Starr MS
Brain Res; 1997 Nov; 777(1-2):51-9. PubMed ID: 9449412
[TBL] [Abstract][Full Text] [Related]
10. Fluoxetine improves the effect of levodopa on 6-hydroxy dopamine-induced motor impairments in rats.
Mahmoudi J; Mohajjel Nayebi A; Reyhani-Rad S; Samini M
Adv Pharm Bull; 2012; 2(2):149-55. PubMed ID: 24312786
[TBL] [Abstract][Full Text] [Related]
11. Catalepsy induced by a blockade of dopamine D1 or D2 receptors was reversed by a concomitant blockade of adenosine A(2A) receptors in the caudate-putamen of rats.
Hauber W; Neuscheler P; Nagel J; Müller CE
Eur J Neurosci; 2001 Oct; 14(8):1287-93. PubMed ID: 11703457
[TBL] [Abstract][Full Text] [Related]
12. Alterations in the turnover rate of dopamine D1 but not D2 receptors in the adult rat neostriatum after a neonatal dopamine denervation.
Dewar KM; Paquet M; Reader TA
Neurochem Int; 1997 Jun; 30(6):613-21. PubMed ID: 9153003
[TBL] [Abstract][Full Text] [Related]
13. Chronic alterations in dopaminergic neurotransmission produce a persistent elevation of deltaFosB-like protein(s) in both the rodent and primate striatum.
Doucet JP; Nakabeppu Y; Bedard PJ; Hope BT; Nestler EJ; Jasmin BJ; Chen JS; Iadarola MJ; St-Jean M; Wigle N; Blanchet P; Grondin R; Robertson GS
Eur J Neurosci; 1996 Feb; 8(2):365-81. PubMed ID: 8714707
[TBL] [Abstract][Full Text] [Related]
14. The significance of rotational behavior and sensitivity of striatal dopamine receptors in hemiparkinsonian rats: A comparative study of lactacystin and 6-OHDA.
Konieczny J; Czarnecka A; Lenda T; Kamińska K; Antkiewicz-Michaluk L
Neuroscience; 2017 Jan; 340():308-318. PubMed ID: 27826109
[TBL] [Abstract][Full Text] [Related]
15. The anti-dyskinetic effect of dopamine receptor blockade is enhanced in parkinsonian rats following dopamine neuron transplantation.
Shin E; Lisci C; Tronci E; Fidalgo C; Stancampiano R; Björklund A; Carta M
Neurobiol Dis; 2014 Feb; 62():233-40. PubMed ID: 24135006
[TBL] [Abstract][Full Text] [Related]
16. Differential contributions of dopaminergic D1- and D2-like receptors to cognitive function in rhesus monkeys.
Von Huben SN; Davis SA; Lay CC; Katner SN; Crean RD; Taffe MA
Psychopharmacology (Berl); 2006 Nov; 188(4):586-96. PubMed ID: 16538469
[TBL] [Abstract][Full Text] [Related]
17. Modulation of dopaminergic and glutamatergic brain function: PET studies on parkinsonian rats.
Pellegrino D; Cicchetti F; Wang X; Zhu A; Yu M; Saint-Pierre M; Brownell AL
J Nucl Med; 2007 Jul; 48(7):1147-53. PubMed ID: 17574972
[TBL] [Abstract][Full Text] [Related]
18. Cerium oxide nanoparticles could ameliorate behavioral and neurochemical impairments in 6-hydroxydopamine induced Parkinson's disease in rats.
Hegazy MA; Maklad HM; Samy DM; Abdelmonsif DA; El Sabaa BM; Elnozahy FY
Neurochem Int; 2017 Sep; 108():361-371. PubMed ID: 28527632
[TBL] [Abstract][Full Text] [Related]
19. Intrastriatal administration of botulinum neurotoxin A normalizes striatal D
Wedekind F; Oskamp A; Lang M; Hawlitschka A; Zilles K; Wree A; Bauer A
J Neurosci Res; 2018 Jan; 96(1):75-86. PubMed ID: 28695985
[TBL] [Abstract][Full Text] [Related]
20. Effects of chronic methamphetamine on SCH23390- or haloperidol-induced catalepsy, and effects of coadministration of SCH23390 or haloperidol in mice.
Mizuki Y; Ushijima I; Yamada M
Pharmacol Biochem Behav; 1996 Feb; 53(2):437-40. PubMed ID: 8808155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
